Report Detail
Global B Cell Maturation Antigen Targeted Therapy Market Growth (Status and Outlook) 2022-2028
- RnM4472598 |
- 26 July, 2022 |
- Global |
- 110 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of B Cell Maturation Antigen Targeted Therapy will have significant change from previous year. According to our (LP Information) latest study, the global B Cell Maturation Antigen Targeted Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global B Cell Maturation Antigen Targeted Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States B Cell Maturation Antigen Targeted Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global B Cell Maturation Antigen Targeted Therapy market, reaching US$ million by the year 2028. As for the Europe B Cell Maturation Antigen Targeted Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main B Cell Maturation Antigen Targeted Therapy players cover GlaxoSmithKline, Johnson & Johnson, Amgen, and Seagen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of B Cell Maturation Antigen Targeted Therapy market by product type, application, key players and key regions and countries.
Segmentation by treatment method: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Antibody-Drug Conjugates
CAR-T Cells and Bispecific T Cell Engagers
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Johnson & Johnson
Amgen
Seagen
AbbVie
Novartis
BioTherapeutics
Celgene
Bluebird Bio
Bristol Mayer Squibb
Carsgen Therapeutics
Juno Therapeutics
Cogent Bioscience
CRISPR Therapeutics
Allogene Therapeutics
Harpoon Therapeutics
Poseida Therapeutics
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global B Cell Maturation Antigen Targeted Therapy Market Size 2017-2028
- 2.1.2 B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 B Cell Maturation Antigen Targeted Therapy Segment by Treatment Method
- 2.2.1 Antibody-Drug Conjugates
- 2.2.2 CAR-T Cells and Bispecific T Cell Engagers
- 2.3 B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method
- 2.3.1 B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Treatment Method (2017 VS 2022 VS 2028)
- 2.3.2 Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)
- 2.4 B Cell Maturation Antigen Targeted Therapy Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Others
- 2.5 B Cell Maturation Antigen Targeted Therapy Market Size by Application
- 2.5.1 B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)
3 B Cell Maturation Antigen Targeted Therapy Market Size by Player
- 3.1 B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Players
- 3.1.1 Global B Cell Maturation Antigen Targeted Therapy Revenue by Players (2020-2022)
- 3.1.2 Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Players (2020-2022)
- 3.2 Global B Cell Maturation Antigen Targeted Therapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 B Cell Maturation Antigen Targeted Therapy by Regions
- 4.1 B Cell Maturation Antigen Targeted Therapy Market Size by Regions (2017-2022)
- 4.2 Americas B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)
- 4.3 APAC B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)
- 4.4 Europe B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)
- 4.5 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas B Cell Maturation Antigen Targeted Therapy Market Size by Country (2017-2022)
- 5.2 Americas B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)
- 5.3 Americas B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC B Cell Maturation Antigen Targeted Therapy Market Size by Region (2017-2022)
- 6.2 APAC B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)
- 6.3 APAC B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe B Cell Maturation Antigen Targeted Therapy by Country (2017-2022)
- 7.2 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)
- 7.3 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa B Cell Maturation Antigen Targeted Therapy by Region (2017-2022)
- 8.2 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)
- 8.3 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.1 Global B Cell Maturation Antigen Targeted Therapy Forecast by Regions (2023-2028)
- 10.1.1 Global B Cell Maturation Antigen Targeted Therapy Forecast by Regions (2023-2028)
- 10.1.2 Americas B Cell Maturation Antigen Targeted Therapy Forecast
- 10.1.3 APAC B Cell Maturation Antigen Targeted Therapy Forecast
- 10.1.4 Europe B Cell Maturation Antigen Targeted Therapy Forecast
- 10.1.5 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Forecast
- 10.2 Americas B Cell Maturation Antigen Targeted Therapy Forecast by Country (2023-2028)
- 10.2.1 United States B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.2.2 Canada B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.2.3 Mexico B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.2.4 Brazil B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.3 APAC B Cell Maturation Antigen Targeted Therapy Forecast by Region (2023-2028)
- 10.3.1 China B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.3.2 Japan B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.3.3 Korea B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.3.4 Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.3.5 India B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.3.6 Australia B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.4 Europe B Cell Maturation Antigen Targeted Therapy Forecast by Country (2023-2028)
- 10.4.1 Germany B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.4.2 France B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.4.3 UK B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.4.4 Italy B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.4.5 Russia B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.5 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Forecast by Region (2023-2028)
- 10.5.1 Egypt B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.5.2 South Africa B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.5.3 Israel B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.5.4 Turkey B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.5.5 GCC Countries B Cell Maturation Antigen Targeted Therapy Market Forecast
- 10.6 Global B Cell Maturation Antigen Targeted Therapy Forecast by Treatment Method (2023-2028)
- 10.7 Global B Cell Maturation Antigen Targeted Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 GlaxoSmithKline
- 11.1.1 GlaxoSmithKline Company Information
- 11.1.2 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 GlaxoSmithKline Main Business Overview
- 11.1.5 GlaxoSmithKline Latest Developments
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Information
- 11.2.2 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Johnson & Johnson Main Business Overview
- 11.2.5 Johnson & Johnson Latest Developments
- 11.3 Amgen
- 11.3.1 Amgen Company Information
- 11.3.2 Amgen B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Amgen Main Business Overview
- 11.3.5 Amgen Latest Developments
- 11.4 Seagen
- 11.4.1 Seagen Company Information
- 11.4.2 Seagen B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Seagen Main Business Overview
- 11.4.5 Seagen Latest Developments
- 11.5 AbbVie
- 11.5.1 AbbVie Company Information
- 11.5.2 AbbVie B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 AbbVie Main Business Overview
- 11.5.5 AbbVie Latest Developments
- 11.6 Novartis
- 11.6.1 Novartis Company Information
- 11.6.2 Novartis B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Novartis Main Business Overview
- 11.6.5 Novartis Latest Developments
- 11.7 BioTherapeutics
- 11.7.1 BioTherapeutics Company Information
- 11.7.2 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 BioTherapeutics Main Business Overview
- 11.7.5 BioTherapeutics Latest Developments
- 11.8 Celgene
- 11.8.1 Celgene Company Information
- 11.8.2 Celgene B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Celgene Main Business Overview
- 11.8.5 Celgene Latest Developments
- 11.9 Bluebird Bio
- 11.9.1 Bluebird Bio Company Information
- 11.9.2 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Bluebird Bio Main Business Overview
- 11.9.5 Bluebird Bio Latest Developments
- 11.10 Bristol Mayer Squibb
- 11.10.1 Bristol Mayer Squibb Company Information
- 11.10.2 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Bristol Mayer Squibb Main Business Overview
- 11.10.5 Bristol Mayer Squibb Latest Developments
- 11.11 Carsgen Therapeutics
- 11.11.1 Carsgen Therapeutics Company Information
- 11.11.2 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Carsgen Therapeutics Main Business Overview
- 11.11.5 Carsgen Therapeutics Latest Developments
- 11.12 Juno Therapeutics
- 11.12.1 Juno Therapeutics Company Information
- 11.12.2 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Juno Therapeutics Main Business Overview
- 11.12.5 Juno Therapeutics Latest Developments
- 11.13 Cogent Bioscience
- 11.13.1 Cogent Bioscience Company Information
- 11.13.2 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Cogent Bioscience Main Business Overview
- 11.13.5 Cogent Bioscience Latest Developments
- 11.14 CRISPR Therapeutics
- 11.14.1 CRISPR Therapeutics Company Information
- 11.14.2 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 CRISPR Therapeutics Main Business Overview
- 11.14.5 CRISPR Therapeutics Latest Developments
- 11.15 Allogene Therapeutics
- 11.15.1 Allogene Therapeutics Company Information
- 11.15.2 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Allogene Therapeutics Main Business Overview
- 11.15.5 Allogene Therapeutics Latest Developments
- 11.16 Harpoon Therapeutics
- 11.16.1 Harpoon Therapeutics Company Information
- 11.16.2 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Harpoon Therapeutics Main Business Overview
- 11.16.5 Harpoon Therapeutics Latest Developments
- 11.17 Poseida Therapeutics
- 11.17.1 Poseida Therapeutics Company Information
- 11.17.2 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered
- 11.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Poseida Therapeutics Main Business Overview
- 11.17.5 Poseida Therapeutics Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on B Cell Maturation Antigen Targeted Therapy. Industry analysis & Market Report on B Cell Maturation Antigen Targeted Therapy is a syndicated market report, published as Global B Cell Maturation Antigen Targeted Therapy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of B Cell Maturation Antigen Targeted Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
